Studies of Antibody-Dependent Enhancement of Human Immunodeficiency Virus (HIV) Type 1 Infection Mediated by Fc Receptors Using Sera from Recipients of a Recombinant gp160 Experimental HIV-1 Vaccine
1992; Oxford University Press; Volume: 165; Issue: 3 Linguagem: Inglês
10.1093/infdis/165.3.545
ISSN1537-6613
AutoresRichard Haubrich, Atsuya Takeda, Wayne C. Koff, Glenn Smith, Francis A. Ennis,
Tópico(s)HIV/AIDS drug development and treatment
ResumoJournal Article Studies of Antibody-Dependent Enhancement of Human Immunodeficiency Virus (HIV) Type 1 Infection Mediated by Fc Receptors Using Sera from Recipients of a Recombinant gp160 Experimental HIV-1 Vaccine Get access Richard H. Haubrich, Richard H. Haubrich Search for other works by this author on: Oxford Academic PubMed Google Scholar Akira Takeda, Akira Takeda Search for other works by this author on: Oxford Academic PubMed Google Scholar Wayne Koff, Wayne Koff Search for other works by this author on: Oxford Academic PubMed Google Scholar Gale Smith, Gale Smith Search for other works by this author on: Oxford Academic PubMed Google Scholar Francis A. Ennis Francis A. Ennis Search for other works by this author on: Oxford Academic PubMed Google Scholar The Journal of Infectious Diseases, Volume 165, Issue 3, March 1992, Pages 545–548, https://doi.org/10.1093/infdis/165.3.545 Published: 01 March 1992 Article history Received: 25 July 1991 Revision received: 24 October 1991 Published: 01 March 1992
Referência(s)